iRhythm Technologies

Traded on the St. Petersburg Stock Exchange
iRhythm Technologies provides diagnostic monitoring solutions that facilitate the early diagnosis and treatment of cardiac arrhythmia.
iRhythm Technologies stock price chart
vol.
change
P/E adj.
Net profit (adj.)
P/B
Book value
P/FCF
FCF
Yield
Growth potential

iRhythm Technologies balance sheet

Report period2018 2019 2020 2021 2022 Q3 23
End date of the reporting period
Capitalization, $
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

iRhythm Technologies cash flows

Report period2018 2019 2020 2021 2022 Q3 23 TTM
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
EBITDA
Adjusted EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS

iRhythm Technologies multipliers

Report period2018 2019 2020 2021 2022 Q3 23 TTM
P/E
P/E adj.
E/P
E adj./P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
Net Debt/EBITDA adj.
EV/EBITDA
EV/EBITDA adj.

iRhythm Technologies profitability

Report period2018 2019 2020 2021 2022 Q3 23 TTM
ROA
ROE
ROS
Gross margin
EBITDA Margin
Operating margin
iRhythm Technologies assets
iRhythm Technologies cash flows

iRhythm Technologies shares

TickerNameTypeNominal valueISINPrice
IRTC:USiRhythm Technologies, Inc.Common share-US4500561067$86.48
iRhythm Technologies news
06.05.2022
iRhythm Technologies' GAAP loss for 3 months of 2022 was $50.609 million, up 82.2% from $27.779 million in the prior year. Revenue increased 24.3% to $92.378 million from $74.311 million a year earlier.
Source: {source} pictogram investors.irhythmtech.com
Pictogram next
24.02.2022
iRhythm Technologies' GAAP loss for 2021 was $101.361 million, up 2.3 times from $43.83 million in the prior year. Revenue increased 21.7% to $322.825 million from $265.166 million a year earlier.
Source: {source} pictogram investors.irhythmtech.com
Pictogram next
05.11.2021
The GAAP loss of iRhythm Technologies for 9M 2021 was $68.87 million, having doubled from $34.179 million in the previous year. Revenues increased by 29.3% to $241.021 million compared to $186.357 million a year earlier.
Source: {source} pictogram investors.irhythmtech.com
Pictogram next
06.08.2021
iRhythm Technologies' GAAP loss for six months of 2021 was $45.139 million, up 53% from $29.502 million in the prior year. Revenue increased 36% to $155.589 million from $114.413 million a year earlier.
Source: {source} pictogram investors.irhythmtech.com
Pictogram next
All iRhythm Technologies news
General information
Company nameiRhythm Technologies
Tags#medtech
SectorHealth Care / Health Care Equipment & Services / Health Care Equipment & Supplies / Health Care Equipment
Business address650 TOWNSEND STREET SUITE 500 San Francisco CA 94103 415-632-5700
Mailing address650 TOWNSEND STREET SUITE 500 San Francisco CA 94103
Websitewww.irhythmtech.com
Information disclosurewww.sec.gov